Article
Coordination of TP53 abnormalities in breast cancer: data from analysis of TP53 polymorphisms, loss of heterozygosity, methylation, and mutations.
Genetic testing and molecular biomarkers - 1 Dec 2011
Denisov Evgeny V, Sukhanovskaya Tatiana V, Dultseva Tatiana S, Malinovskaya Elena A, Litviakov Nicolay V, Slonimskaya Elena M, Choinzonov Evgeny L, Cherdyntseva Nadezhda V
Abstract excerpt
AIMS: We have studied whether TP53 rs1042522, rs17878362, and rs1625895 alleles having a protective effect against breast cancer (BC) will be lost in tumors, whereas those allowing disease development will be retained. METHODS: Analysis of TP53 polymorphisms was performed in blood leukocytes and tumors from 80 Caucasian BC patients. In addition, TP53 loss of heterozygosity (LOH), methylation, and mutations were...
Read the complete abstract on PubMed